Quick Answer
ACTUATE THERAPEUTICS, INC. reported Net Income of -$22.23 million for fiscal year 2025.
ACTUATE THERAPEUTICS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$22.23M | +18.5% |
| 2024 | -$27.29M | -10.3% |
| 2023 | -$24.74M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$5.41M | +9.4% | +9.1% |
| June 30, 2025 | -$5.95M | +9.5% | +5.8% |
| March 31, 2025 | -$6.32M | +23.9% | -5.8% |
| September 30, 2024 | -$5.97M | +5.8% | +9.1% |
| June 30, 2024 | -$6.57M | -19.0% | +20.8% |
| March 31, 2024 | -$8.30M | -57.4% | -30.9% |
| September 30, 2023 | -$6.34M | — | -14.7% |
| June 30, 2023 | -$5.52M | — | -4.8% |
- ACTUATE THERAPEUTICS, INC. showed an increase of +18.5% in Net Income compared to the prior fiscal year.
- Over the 2023–2025 period, ACTUATE THERAPEUTICS, INC.’s net income has grown by 10.2% (from -$24.74 million to -$22.23 million).
- The most recent figure is from ACTUATE THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: